Director, Quality – New Product Development Lead

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To support our continued growth, we are strengthening our workforce strategy to ensure we have the right talent, at the right time, in the right way. Leads development quality strategy and execution across the new product development portfolio, ensuring phase-appropriate controls and consistent governance across programs and modalities. Establishes operating model expectations, standards, and performance cadences for development QA delivery. Partners with CMC and clinical supply leaders to embed quality risk management early, align readiness milestones, and enable efficient progression toward commercialization. Sets partner / vendor oversight standards and ensures inspection readiness through controlled documentation and audit-ready narratives. Sponsors continuous improvement to increase predictability, throughput, and right-first-time documentation.  Key Responsibilities   Portfolio Leadership & Operating Model   Define development quality operating model, governance forums, and performance metrics, ensure consistent decision quality across programs  Prioritize portfolio support and escalate resource, timeline, and quality risks with mitigation options  Produce deliverables such as portfolio dashboards, governance calendars, and resourcing / risk briefs  Development Oversight & Partner Governance   Ensure phase-appropriate QMS application and documentation traceability across programs and external partners  Set expectations for vendor oversight, audits, issue management, and readiness deliverables  Produce deliverables such as vendor oversight standards, audit strategies, and readiness playbooks  Inspection Readiness & Continuous Improvement   Maintain readiness for development inspections and submission support, ensure narratives and evidence are current and retrievable  Sponsor CI initiatives to improve cycle time, RFT documentation, and predictable execution across the portfolio  Produce deliverables such as inspection readiness plans, evidence indexes, and CI roadmaps / benefits trackers  Required Qualifications   BS+ Life Sciences / Engineering (or related)  12–15 years QA experience with significant development portfolio leadership experience  Demonstrated people leadership and executive stakeholder influence  Preferred Qualifications   Experience in pharmaceutical / biotech across multiple modalities and external development networks (preferred)  Experience supporting inspections and major submissions / filings readiness  Key Competencies    Portfolio leadership, operating model design, and governance discipline, prioritization, resourcing, and performance cadence ownership  Cross-functional leadership, escalation, and executive-ready risk / decision communication  Partner governance and performance management across external development networks, audit / inspection readiness planning  Quality risk management, phase-appropriate QMS application, and readiness milestone governance across programs  Change management (stakeholder mapping, communications, training / standardization readiness, adoption measurement) and continuous improvement sponsorship  Veeva Vault Quality (eQMS) proficiency to enable portfolio governance visibility and inspection-ready documentation control  Madrigal’s Total Rewards strategy is based on a biotech industry peer group comparator and is inclusive of base pay, bonus and equity. Our equity offers meaningful opportunity allowing our employees to share in the success they help create. By aligning individual and company performance, we empower employees to think like owners, giving them a stake in the organization. All employees receive equity, which we believe reinforces our ownership culture. Base salary is determined by several factors including the candidate’s qualifications, skills, education, experience, business needs and market demands.  As of the date of this posting, a good faith estimate of the current pay scale for this position, applicable to all candidates, is $211,591 - $240,461 per year.  We comply with all applicable minimum wage laws. All full-time employees receive equity, which reinforces our ownership culture and offers meaningful opportunity for our employees to share in the success they help create. By aligning individual and company performance, we empower employees to think like owners, giving them a stake in the organization.   Full-time employees are also eligible for comprehensive benefits, including flexible paid time off, medical, dental, vision and life/disability insurance, and 401(k) offerings (i.e., traditional, Roth, and employer match) in accordance with applicable plans. We also offer additional voluntary benefits like supplemental life insurance, legal services, and other offerings. In addition, we offer mental health benefits through our Employee Assistance Program for employees and their family. The company also provides other benefits in accordance with applicable federal, state, and local laws.  We are committed t